RFK Jr. serves as HHS Secretary following his narrow 2025 Senate confirmation and remains aligned with the Trump administration’s health policy agenda into late 2026. Recent actions include leadership reorganizations at HHS, advancement of MAHA priorities on vaccines and food standards, and participation in a presidential executive order reshaping childhood vaccine recommendations. Earlier rumors of an imminent departure were denied by the department, and no resignation signals or removal proceedings have emerged. Traders assign a 73% implied probability that he completes the year in the role, reflecting sustained White House backing, ongoing policy implementation ahead of midterms, and the absence of procedural steps or credible reports indicating an exit before December 31.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano$24,303 Wol.
$24,303 Wol.
$24,303 Wol.
$24,303 Wol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Rynek otwarty: Mar 19, 2026, 2:02 PM ET
Rozstrzygający
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Rozstrzygający
0x65070BE91...RFK Jr. serves as HHS Secretary following his narrow 2025 Senate confirmation and remains aligned with the Trump administration’s health policy agenda into late 2026. Recent actions include leadership reorganizations at HHS, advancement of MAHA priorities on vaccines and food standards, and participation in a presidential executive order reshaping childhood vaccine recommendations. Earlier rumors of an imminent departure were denied by the department, and no resignation signals or removal proceedings have emerged. Traders assign a 73% implied probability that he completes the year in the role, reflecting sustained White House backing, ongoing policy implementation ahead of midterms, and the absence of procedural steps or credible reports indicating an exit before December 31.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano



Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania